Avantor Inc (AVTR) Stock Price, Quote & News

Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610 386 1700

Website: www.avantorsciences.com

Address:

Radnor Corporate Center, Building One Suite 200 100 Matsonford Road, Radnor, United States

Invescent Aug. 28 at 1:35 PM

📊 Today's Trade Ideas 1️⃣ $PATH Bullish Setup • 71% Entry: $18.24 - $18.39 Target: $19.43 Stop: $17.60 Risk: Low 2️⃣ $FNDA Momentum Setup • 54% Entry: $37.46 - $37.67 Target: $39.88 Stop: $36.12 Risk: High 3️⃣ $AVTR Watchlist Setup • 44% Entry: $14.54 - $14.70 Target: $15.49 Stop: $14.03 Risk: Low Not financial advice.

0 · Reply

Invescent Aug. 27 at 1:35 PM

📊 Today's Trade Ideas 1️⃣ $FNDA Momentum Setup • 44% Entry: $37.51 - $37.73 Target: $39.89 Stop: $36.12 Risk: High 2️⃣ $ONON Watchlist Setup • 40% Entry: $29.08 - $29.40 Target: $30.98 Stop: $28.06 Risk: Low 3️⃣ $AVTR Watchlist Setup • 36% Entry: $14.43 - $14.63 Target: $15.37 Stop: $13.92 Risk: Low Not financial advice.

0 · Reply

Invescent Aug. 26 at 1:35 PM

📊 Today's Trade Ideas 1️⃣ $HUT Momentum Setup • 59% Entry: $85.07 - $85.69 Target: $90.63 Stop: $82.08 Risk: Low 2️⃣ $DAR Watchlist Setup • 44% Entry: $62.27 - $63.19 Target: $66.33 Stop: $60.08 Risk: Low 3️⃣ $AVTR Watchlist Setup • 44% Entry: $14.35 - $14.50 Target: $15.29 Stop: $13.84 Risk: Low Not financial advice.

0 · Reply

Estimize Aug. 24 at 10:09 AM

Wall St is expecting 0.21 EPS for $AVTR Q3 [Reporting 10/23 BMO] http://www.estimize.com/intro/avtr?chart=historical&metric_name=eps&utm_co

0 · Reply

Invescent Aug. 21 at 1:35 PM

📊 Today's Trade Ideas 1️⃣ $HUT Momentum Setup • 59% Entry: $88.21 - $89.11 Target: $93.97 Stop: $85.10 Risk: Low 2️⃣ $ONON Watchlist Setup • 44% Entry: $29.75 - $30.35 Target: $31.69 Stop: $28.70 Risk: Low 3️⃣ $AVTR Watchlist Setup • 44% Entry: $14.18 - $14.46 Target: $15.11 Stop: $13.68 Risk: Low Not financial advice.

0 · Reply

SaltWaterChickens Aug. 19 at 3:00 PM

$AVTR close to a double up from my entry you dirty

0 · Reply

Your_friend_Satan Aug. 14 at 1:34 PM

$BSX Insiders loading. They did the same at $GEHC and $AVTR which both recently started a new uptrend.

0 · Reply

Estimize Aug. 10 at 10:21 AM

Wall St is expecting 0.21 EPS for $AVTR Q3 [Reporting 10/23 BMO] http://www.estimize.com/intro/avtr?chart=historical&metric_name=eps&utm_co

0 · Reply

johnnylawrencecobra Jul. 31 at 8:06 PM

$AVTR $OXBR

0 · Reply

Your_friend_Satan Jul. 31 at 3:10 PM

$AVTR $GEHC Come on you turds! Neither of you going to hold the earnings gap??

0 · Reply

Avantor price target raised to $14 from $10 at Morgan Stanley

2026-07-30T13:50:33.000Z - 4 weeks ago

Avantor price target raised to $14 from $9 at RBC Capital

2026-07-30T13:22:20.000Z - 4 weeks ago

Avantor price target raised to $12 from $8 at JPMorgan

2026-07-30T12:41:55.000Z - 4 weeks ago

Avantor price target raised to $14 from $10.50 at Evercore ISI

2026-07-30T12:25:33.000Z - 4 weeks ago

Avantor price target raised to $13 from $11 at Deutsche Bank

2026-07-30T11:21:56.000Z - 4 weeks ago

Avantor price target raised to $15 from $8 at Stifel

2026-07-29T20:00:35.000Z - 4 weeks ago

Avantor upgraded to Hold from Underperform at Jefferies

Jul 29, 2026, 8:00 AM EDT - 4 weeks ago

Avantor Earnings Call Transcript: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 4 weeks ago

Avantor Earnings release: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 4 weeks ago

Avantor Slides: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 4 weeks ago

Avantor Quarterly report: Q2 2026

2026-07-29T10:26:12.000Z - 4 weeks ago

Avantor reports Q2 adjusted EPS 21c, consensus 19c

2026-07-29T10:25:30.000Z - 4 weeks ago

Avantor narrows FY26 adjusted EPS view to 80c-83c from 77c-83c, consensus 79c

Jul 29, 2026, 6:05 AM EDT - 4 weeks ago

Avantor® Reports Second Quarter 2026 Results

2026-07-15T12:46:04.000Z - 6 weeks ago

Avantor price target raised to $11 from $9 at TD Cowen

2026-07-14T12:15:34.000Z - 6 weeks ago

Avantor’s NuSil partners with The Population Council for HIV prevention

Jul 14, 2026, 8:05 AM EDT - 6 weeks ago

Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product

2026-07-08T10:45:26.000Z - 7 weeks ago

Avantor price target raised to $11 from $9 at Citi

2026-07-06T12:40:20.000Z - 7 weeks ago

Avantor price target raised to $10.50 from $8 at Evercore ISI

Jul 1, 2026, 8:05 AM EDT - 2 months ago

Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026

2026-06-26T10:25:08.000Z - 2 months ago

Avantor resumed with a Market Perform at Bernstein

2026-06-24T08:50:13.000Z - 2 months ago

Avantor price target raised to $8 from $7 at Barclays

2026-06-01T20:56:03.000Z - 3 months ago

Avantor assumed with Underperform at Wolfe Research

2026-06-01T20:22:51.000Z - 3 months ago

Avantor assumed with Underperform from Peer Perform at Wolfe Research

May 19, 2026, 6:05 AM EDT - 3 months ago

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

2026-05-14T20:46:32.000Z - 3 months ago

Avantor resumed with a Sector Perform at RBC Capital

May 7, 2026, 11:00 AM EDT - 4 months ago

Avantor Transcript: AGM 2026

2026-04-30T16:45:54.000Z - 4 months ago

Avantor price target lowered to $8 from $8.50 at Evercore ISI

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Avantor Earnings Call Transcript: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Avantor Earnings release: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Avantor Slides: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Avantor Quarterly report: Q1 2026

Apr 29, 2026, 6:05 AM EDT - 4 months ago

Avantor® Reports First Quarter 2026 Results

Apr 23, 2026, 5:05 PM EDT - 4 months ago

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Apr 21, 2026, 8:05 AM EDT - 4 months ago

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Apr 13, 2026, 8:05 AM EDT - 4 months ago

Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility

Apr 3, 2026, 8:05 AM EDT - 5 months ago

Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026

Apr 1, 2026, 8:00 AM EDT - 5 months ago

Avantor® Announces CFO Transition

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Avantor Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Avantor Proxy statement: Proxy filing

Feb 11, 2026, 8:00 AM EST - 7 months ago

Avantor Earnings Call Transcript: Q4 2025

Feb 11, 2026, 8:00 AM EST - 7 months ago

Avantor Annual report: Q4 2025

Feb 11, 2026, 8:00 AM EST - 7 months ago

Avantor Earnings release: Q4 2025

Feb 11, 2026, 8:00 AM EST - 7 months ago

Avantor Slides: Q4 2025

Feb 11, 2026, 6:05 AM EST - 7 months ago

Avantor® Reports Fourth Quarter and Full Year 2025 Results

Jan 14, 2026, 11:15 AM EST - 8 months ago

Avantor Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 11:15 AM EST - 8 months ago

Avantor Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 7:30 AM EST - 8 months ago

p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor

Jan 12, 2026, 8:05 AM EST - 8 months ago

Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Jan 5, 2026, 8:05 AM EST - 8 months ago

Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference

Dec 18, 2025, 8:05 AM EST - 9 months ago

Avantor® Appoints Simon Dingemans to its Board of Directors

Dec 15, 2025, 1:45 AM EST - 9 months ago

AVANTOR, INC. (NYSE: AVTR) DEADLINE ALERT Bernstein Liebhard LLP Reminds Avantor, Inc. Investors of Upcoming Deadline

Dec 4, 2025, 4:15 PM EST - 9 months ago

Avantor® Appoints Sanjeev Mehra to its Board of Directors

Nov 25, 2025, 8:05 AM EST - 9 months ago

Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology

Nov 19, 2025, 8:05 AM EST - 10 months ago

Avantor® Expands Centralized Service Center Model with Opening of Boston-Area Facility

Nov 10, 2025, 8:30 AM EST - 10 months ago

Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer

Oct 31, 2025, 10:20 AM EDT - 10 months ago

AVANTOR, INC. (NYSE: AVTR) INVESTOR ALERT Investors With Large Losses in Avantor, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Oct 30, 2025, 8:05 AM EDT - 10 months ago

Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Avantor Earnings Call Transcript: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Avantor Quarterly report: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Avantor Earnings release: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Avantor Slides: Q3 2025

Oct 29, 2025, 6:05 AM EDT - 10 months ago

Avantor® Reports Third Quarter 2025 Results

Oct 23, 2025, 8:05 AM EDT - 11 months ago

Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

Oct 15, 2025, 8:05 AM EDT - 11 months ago

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

Oct 13, 2025, 4:05 PM EDT - 11 months ago

Avantor® Announces Board Chairman Transition

Oct 3, 2025, 8:05 AM EDT - 11 months ago

Avantor® Appoints Gregory T. Lucier to its Board of Directors

Oct 1, 2025, 8:05 AM EDT - 11 months ago

Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025

Invescent Aug. 28 at 1:35 PM

0 · Reply

Invescent Aug. 27 at 1:35 PM

0 · Reply

Invescent Aug. 26 at 1:35 PM

0 · Reply

Estimize Aug. 24 at 10:09 AM

Wall St is expecting 0.21 EPS for $AVTR Q3 [Reporting 10/23 BMO] http://www.estimize.com/intro/avtr?chart=historical&metric_name=eps&utm_co

0 · Reply

Invescent Aug. 21 at 1:35 PM

0 · Reply

SaltWaterChickens Aug. 19 at 3:00 PM

$AVTR close to a double up from my entry you dirty

0 · Reply

Your_friend_Satan Aug. 14 at 1:34 PM

$BSX Insiders loading. They did the same at $GEHC and $AVTR which both recently started a new uptrend.

0 · Reply

Estimize Aug. 10 at 10:21 AM

Wall St is expecting 0.21 EPS for $AVTR Q3 [Reporting 10/23 BMO] http://www.estimize.com/intro/avtr?chart=historical&metric_name=eps&utm_co

0 · Reply

johnnylawrencecobra Jul. 31 at 8:06 PM

$AVTR $OXBR

0 · Reply

Your_friend_Satan Jul. 31 at 3:10 PM

$AVTR $GEHC Come on you turds! Neither of you going to hold the earnings gap??

0 · Reply

LPStakesIQ Jul. 30 at 5:56 PM

$AVTR AITX continues demonstrating how autonomous security can scale across large, dynamic construction environments.

0 · Reply

MarketFractal Jul. 30 at 5:40 PM

$AVTR picked up fresh analyst target increases. Helpful for sentiment, but price targets alone don't change the investment case. The business still has to deliver.

1 · Reply

Invescent Jul. 30 at 1:35 PM

📊 Today's Trade Ideas 1️⃣ $AVTR Strong Bullish Setup • 100% Entry: $14.31 - $14.60 Target: $15.24 Stop: $13.80 Risk: Medium 2️⃣ $HUT Watchlist Setup • 44% Entry: $87.74 - $89.50 Target: $93.47 Stop: $84.65 Risk: Low 3️⃣ $HBM Watchlist Setup • 40% Entry: $21.87 - $22.31 Target: $23.30 Stop: $21.10 Risk: Low Not financial advice.

0 · Reply

Estimize Jul. 29 at 10:03 PM

$AVTR reported 0.21 EPS and 1,692 revenue for Q2. http://www.estimize.com/intro/avtr?chart=historical&metric_name=eps&utm_content=AVTR&utm_

0 · Reply

topstockalerts Jul. 29 at 8:09 PM

$AVTR the strength here is subtle but persistent.

0 · Reply

OpenOutcrier Jul. 29 at 8:05 PM

RECAP 7/29 -Neg Comments: $AAUC - National Bank $GNTX - Freedom Broker $SLXN - Maxim $AVTR - Jefferies Live Breaking trading news www.openoutcrier.com

0 · Reply

StayingGreen Jul. 29 at 3:00 PM

$AVTR New short position at 13.80, looking for an exit below 13.50. 31% runup to and after ER, bound for a pullback

0 · Reply

H73 Jul. 29 at 1:47 PM

$AVTR as of July 15, 56 Mill short

0 · Reply

Your_friend_Satan Jul. 29 at 1:27 PM

$GEHC $AVTR Good reaction to earnings so far.

0 · Reply

EarningsInsider Jul. 29 at 1:17 PM

https://www.marketbeat.com/earnings/reports/2026-7-29-avantor-inc-stock/ $AVTR Avantor Earnings Transcript

0 · Reply

SilverEagle Jul. 29 at 1:16 PM

$AVTR strong ER

0 · Reply

itsrucka Jul. 29 at 1:14 PM

$AVTR thank you Mr President 🎰🎰🎰

0 · Reply

Market Cap	9.88B
Revenue (ttm)	6.55B
Net Income (ttm)	-530.20M
EPS (ttm)	N/A
PE Ratio	17.68
Forward PE	17.89
Profit Margin	-8.09%
Debt to Equity Ratio	0.66

Volume	5,301,500
Avg Vol	9,559,820
Day's Range	N/A - N/A
Shares Out	676.36M
Stochastic %K	91%
Beta	0.89
Analysts	Sell
Price Target	$14.59